2 - TI Pharma

17. Kaplan SA, Shimizu CS. Effects of cortisol on amino acids in skeletal muscle and plasma.
Endocrinology. 1963; 72:267-72
18. Lecocq FR, Mebane D, Madison LL. The acute effect of hydrocortisone on hepatic glucose output and
peripheral glucose utilization j Clin Invest. 1964; 43:237-46
19. Munck A. Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence,
molecular mechanisms, and physiological significance. Perspect Biol Med. 1971; 14(2):265-9
20. Ninomiya R, Forbath NF, Hetenyi G, jr. Effect of adrenal steroids on glucose kinetics in normal and
diabetic dogs. Diabetes. 1965; 14(11):729-39
21. Tomas FM, Munro HN, Young VR. Effect of glucocorticoid administration on the rate of muscle
protein breakdown in vivo in rats, as measured by urinary excretion of N tau-methylhistidine.
Biochem j. 1979; 178(1):139-46
22. Björntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med
Scand Suppl. 1988; 723:121-34.
23. Morton NM, Seckl jR. 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Front Horm Res.
2008; 36:146-64
24. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans
RM. Primary structure and expression of a function human glucocorticoid receptor cDNA. Nature.
1985; 318(6047):635-41.
25. Rosen j, Miner jN. The search for safer glucocorticoid receptor ligands. Endocr Rev 2005; 26(3):452-
64
26. McMaster A, Ray DW. Modelling the glucocorticoid receptor and producing therapeutic agents with
anti-inflammatory effects but reduced side-effects. Exp Physiol. 2007; 92(2):299-309
27. Lowenberg M, Stahn C, Hommes DW, Buttgereit F. Novel insights into mechanisms of glucocorticoid
action and the development of new glucocorticoid receptor ligands. Steroids. 2008; 73(9-10):1025-
9
28. Schacke H, Rehwinkel H, Asadullah K, Cato AC. Insight into the molecular mechanisms of
glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic
index. Exp Dermatol. 2006; 15(8):565-73
29. Schacke H, Berger M, Rehwinkel H, Asadullah K. Selective glucocorticoid receptor agonists (SEGRAs):
novel ligands with an improved therapeutic index. Mol Cell Endocrinol 2007; 275(1-2):109-17
30. Song IH, Gold R, Straub RH, Burmester GR, Buttgereit F. New glucocorticoids on the horizon: repress,
don’t activate! J Rheumatol. 2005; 32(7):1199-1207
31. Stahn C, Lowenberg M, Hommes DW, Buttgereit F. Molecular mechanisms of glucocorticoid action
and selective glucocorticoid receptor agonists. Mol Cell Endocrinol. 2007; 275(1-2):71-8
19
1
Chapter 1